Comments
Loading...
Jazz Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:JAZZ | Benzinga
Jazz Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$4.760
Quarterly Revenue Estimate
$984.16M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$4.07B
Analyze the earnings history of Jazz Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals | $5.30 | — | — | — | $1.02B | — | — | — | 07/30/2025 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $2.68 | $4.76 | — | — | $901.98M | $984.16M | — | — | 05/06/2025 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $5.02 | $5.81 | $6.60 | 13.60% | $1.01B | $1.06B | $1.09B | 2.64% | 02/25/2025 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.84 | $5.50 | $6.61 | 20.18% | $972.14M | $1.04B | $1.05B | 1.44% | 11/06/2024 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.51 | $4.80 | $5.30 | 10.42% | $957.32M | $1.01B | $1.02B | 1.39% | 07/31/2024 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $3.95 | $4.18 | $2.68 | -35.89% | $892.81M | $953.90M | $901.98M | -5.44% | 05/01/2024 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | -$0.07 | $5.16 | $5.02 | -2.71% | $972.12M | $1.01B | $1.01B | 0.20% | 02/28/2024 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $5.17 | $4.91 | $4.84 | -1.43% | $940.65M | $965.73M | $972.14M | 0.66% | 11/08/2023 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.30 | $4.43 | $4.51 | 1.81% | $932.88M | $942.86M | $957.32M | 1.53% | 08/09/2023 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $3.73 | $4.24 | $3.95 | -6.84% | $813.72M | $895.37M | $892.81M | -0.29% | 05/10/2023 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.21 | $0.32 | -$0.07 | -121.88% | $896.73M | $975.59M | $972.12M | -0.36% | 03/01/2023 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.20 | $4.66 | $5.17 | 10.94% | $838.12M | $939.06M | $940.65M | 0.17% | 11/09/2022 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $3.90 | $4.20 | $4.30 | 2.38% | $751.81M | $904.21M | $932.88M | 3.17% | 08/03/2022 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $3.92 | $3.83 | $3.73 | -2.61% | $607.58M | $853.52M | $813.72M | -4.66% | 05/04/2022 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.00 | $3.63 | $4.21 | 15.98% | $665.52M | $865.88M | $896.73M | 3.56% | 03/01/2022 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.31 | $3.31 | $4.20 | 26.89% | $600.89M | $832.52M | $838.12M | 0.67% | 11/09/2021 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $3.71 | $3.42 | $3.90 | 14.04% | $562.44M | $735.62M | $751.81M | 2.20% | 08/03/2021 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $0.45 | $3.74 | $3.92 | 4.81% | $534.73M | $611.49M | $607.58M | -0.64% | 05/04/2021 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.42 | $4.20 | $4.00 | -4.76% | $581.74M | $639.55M | $665.52M | 4.06% | 02/23/2021 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.10 | $4.08 | $4.31 | 5.64% | $537.70M | $577.58M | $600.89M | 4.04% | 11/02/2020 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $4.05 | $3.11 | $3.71 | 19.29% | $534.13M | $504.65M | $562.44M | 11.45% | 08/04/2020 | Get Alert |
| JAZZ | Jazz Pharmaceuticals | $1.47 | $0.67 | $0.45 | -32.84% | $508.19M | $543.59M | $534.73M | -1.63% | 05/05/2020 | Get Alert |
Jazz Pharmaceuticals (JAZZ) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $6.60 | $5.81 | 13.6 % |
| Q3 | 2024-11-06 | $6.61 | $5.50 | 20.2 % |
| Q2 | 2024-07-31 | $5.30 | $4.80 | 10.4 % |
| Q1 | 2024-05-01 | $2.68 | $4.18 | -35.9 % |
Jazz Pharmaceuticals (JAZZ) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $1.09B | $1.06B | 2.64 % |
| Q3 | 2024-11-06 | $1.06B | $1.04B | 1.44 % |
| Q2 | 2024-07-31 | $1.02B | $1.01B | 1.39 % |
| Q1 | 2024-05-01 | $901.98M | $953.90M | -5.44 % |
FAQ
When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?
Jazz Pharmaceuticals (JAZZ) is scheduled to report earnings on July 30, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Jazz Pharmaceuticals (NASDAQ:JAZZ)?
The Actual EPS was $6.60, which beat the estimate of $5.81.
What were Jazz Pharmaceuticals’s (NASDAQ:JAZZ) revenues?
The Actual Revenue was $1.1B, which beat the estimate of $1.1B.
Browse earnings estimates, EPS, and revenue on all stocks.
